A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration. Researchers have discovered that an experimental compound called K884 can boost the natural repair abilities of muscle stem cells. Current treatments can slow muscle damage, but don’t address the root problem.
Categories
Recent Posts
- Finding harmony and inclusion in life through music
- CureDuchenne’s latest investment aims to address the limitations of current AAV-delivered gene therapy treatments for Duchenne muscular dystrophy (DMD).
- Elevidys halted in nonambulatory DMD after second death reported
- Insights by Ira: Let’s Get Active This Summer!
- A Safety Update on ELEVIDYS – June 2025